510(k) K260160
K260160 is an FDA 510(k) premarket notification submitted by bioMerieux, Inc. for the device "VITEK REVEAL GN AST Assay and VITEK REVEAL AST System". The FDA issued a decision of Substantially Equivalent on July 8, 2026. The device falls under product code SAN (Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples), a Class II device regulated under 21 CFR 866.1650. bioMerieux, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 8, 2026
- Date Received
- January 20, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Automated Antimicrobial Susceptibility Test System For Positive Blood Culture Samples
- Device Class
- Class II
- Regulation Number
- 866.1650
- Review Panel
- MI
- Submission Type
Automated system that performs antimicrobial susceptibility testing using positive blood culture samples